Popular Articles

Genzyme Receives European Approval Of Renvela For Patients With Chronic Kidney Disease
Genzyme Corporation (Nasdaq: GENZ) announced that the European Commission has approved Renvela(R) (sevelamer carbonate) for the control of serum phosphorus in patients with chronic kidney disease (CKD). The approval includes patients not on dialysis with serum phosphorus levels greater than or equal to 1.78 mmol/L (5.5 mg/dL), and covers both the tablet and powder formulations.
generic viagra online
Stanford Study Recruiting Participants Who Have Insomnia And Depression
"You"ll feel better after a good night"s sleep." We"ve all heard those words, but have we ever stopped to wonder about the mental health of people who just aren"t able to sleep well? Rachel Manber has, and the Stanford University School of Medicine researcher is trying to identify the best way to treat patients suffering from both depression and insomnia.
plastic surgery before after
News of the day
LEAD-6 Study Shows Better Results With Liraglutide Than Exenatide In Controlling Blood Glucose In Type 2 Diabetes
The results of the LEAD-6 study are published in an article Online First and in a future edition of The Lancet. The findings are presented at the same time at the American Diabetes Association meeting in New Orleans, USA. They indicate that taking liraglutide once a day is more efficient in controlling blood glucose in type 2 diabetes than the presently marketed treatment - two doses a day of exenatide.
Sexual Health

Japan Revises SSRI Warnings--Hostility, Violence

In Japan reports of violence linked to SSRI antidepressants have raised public awareness to the danger these drugs can pose. A Japanese psychiatrist acknowledges: "To say that being able to tell the difference between depressives and mild manic-depressives is the test of a psychiatrist"s true skill is no exaggeration." The absence of any empirically valid diagnostic tool in psychiatry puts patients at risk of trial and error --i.e., Russian roulette--diagnostic and treatment methods She indicates that The Japanese Ministry of Health, Labor and Welfare has investigated news reports about antidepressant users "who developed increased feelings of hostility or anxiety, and have even committed sudden acts of violence against others." After its investigation, the Ministry decided to revise the label warnings on SSRI antidepressant stating, "There are cases where we cannot rule out a causal relationship [of hostility, anxiety, and sudden acts of violence] with the medication." So, why are millions of American children being prescribed a class of mind-altering drugs that in some people INDUCE VIOLENCE against self and others? See, SSRI Stories, a website that chronicles news reports about violence, murder and suicide in which SSRIs were implicated. So far there are 3,000 news reports posted: http://ssristories.com/ Alliance for Human Research Protection


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):